Stockreport

Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year [Yahoo! Finance]

iTeos Therapeutics, Inc.  (ITOS) 
PDF The top 11 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa [Read more]